Latest News about REGN
Recent news which mentions REGN
From Motley Fool
 From Motley Fool
 
   Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
   
  
  
  April 04, 2025
  From Benzinga
 From Benzinga
 
   Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
   
  
  
  March 28, 2025
  From Benzinga
 
   Why Pharma and Biotech Stocks Got Thrashed on Tuesday
   
  
  
  March 25, 2025
  From Motley Fool
 
   Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
   
  
  
  March 24, 2025
  From Benzinga
 From Benzinga
 
   Price Over Earnings Overview: Regeneron Pharmaceuticals
   
  
  
  March 18, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 Tickers 
   REGN
  
  
  From Motley Fool
 
   Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
   
  
  
  March 07, 2025
  From Benzinga
 
   Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial
   
  
  
  March 03, 2025
  From Benzinga
 
   Regeneron Touts Encouraging Early Data From Investigational Gene Therapy For Rare Form Of Hearing Loss
   
  
  
  February 25, 2025
  From Benzinga
 
   Price Over Earnings Overview: Regeneron Pharmaceuticals
   
  
  
  February 21, 2025
  From Benzinga
 
   This Company Just Initiated a Quarterly Dividend: Time to Buy?
   
  February 18, 2025
  Tickers 
   REGN
  
  
  From Motley Fool
 
   Looking Into Regeneron Pharmaceuticals's Recent Short Interest
   
  February 17, 2025
  Tickers 
   REGN
  
  
  From Benzinga
 
   Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
   
  
  
  February 14, 2025
  From Benzinga
 
   Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
   
  
  
  February 10, 2025
  From Benzinga
 
   Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
   
  
  
  February 10, 2025
  From Motley Fool
 
   Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
   
  
  
  February 07, 2025
  From Benzinga
 
   Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
   
  
  
  February 04, 2025
  From Motley Fool
 
   US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
   
  
  
  February 04, 2025
  From Benzinga
 
   Regeneron Pharma Q4 Earnings Crush Estimates, Initiates Dividend And Additional Stock Buyback Program
   
  
  
  February 04, 2025
  From Benzinga
 
   Earnings Scheduled For February 4, 2025
   
  
  
  February 04, 2025
  From Benzinga
 
   9 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  January 28, 2025
  From Benzinga
 
   Looking Into Regeneron Pharmaceuticals's Recent Short Interest
   
  January 24, 2025
  Tickers 
   REGN
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
